Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sarah Hunt is active.

Publication


Featured researches published by Sarah Hunt.


Nature | 2010

Integrating common and rare genetic variation in diverse human populations.

David Altshuler; Richard A. Gibbs; Leena Peltonen; Emmanouil T. Dermitzakis; Stephen F. Schaffner; Fuli Yu; Penelope E. Bonnen; de Bakker Pi; Panos Deloukas; Stacey Gabriel; R. Gwilliam; Sarah Hunt; Michael Inouye; Xiaoming Jia; Aarno Palotie; Melissa Parkin; Pamela Whittaker; Kyle Chang; Alicia Hawes; Lora Lewis; Yanru Ren; David A. Wheeler; Donna M. Muzny; C. Barnes; Katayoon Darvishi; Joshua M. Korn; Kristiansson K; Cin-Ty A. Lee; McCarrol Sa; James Nemesh

Despite great progress in identifying genetic variants that influence human disease, most inherited risk remains unexplained. A more complete understanding requires genome-wide studies that fully examine less common alleles in populations with a wide range of ancestry. To inform the design and interpretation of such studies, we genotyped 1.6 million common single nucleotide polymorphisms (SNPs) in 1,184 reference individuals from 11 global populations, and sequenced ten 100-kilobase regions in 692 of these individuals. This integrated data set of common and rare alleles, called ‘HapMap 3’, includes both SNPs and copy number polymorphisms (CNPs). We characterized population-specific differences among low-frequency variants, measured the improvement in imputation accuracy afforded by the larger reference panel, especially in imputing SNPs with a minor allele frequency of ≤5%, and demonstrated the feasibility of imputing newly discovered CNPs and SNPs. This expanded public resource of genome variants in global populations supports deeper interrogation of genomic variation and its role in human disease, and serves as a step towards a high-resolution map of the landscape of human genetic variation.


Nature Genetics | 2010

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1

Amy Strange; Francesca Capon; Chris C. A. Spencer; Jo Knight; Michael E. Weale; Michael H. Allen; Anne Barton; Céline Bellenguez; Judith G.M. Bergboer; Jenefer M. Blackwell; Elvira Bramon; Suzannah Bumpstead; Juan P. Casas; Michael J. Cork; Aiden Corvin; Panos Deloukas; Alexander Dilthey; Audrey Duncanson; Sarah Edkins; Xavier Estivill; Oliver FitzGerald; Colin Freeman; Emiliano Giardina; Emma Gray; Angelika Hofer; Ulrike Hüffmeier; Sarah Hunt; Alan D. Irvine; Janusz Jankowski; Brian J. Kirby

To identify new susceptibility loci for psoriasis, we undertook a genome-wide association study of 594,224 SNPs in 2,622 individuals with psoriasis and 5,667 controls. We identified associations at eight previously unreported genomic loci. Seven loci harbored genes with recognized immune functions (IL28RA, REL, IFIH1, ERAP1, TRAF3IP2, NFKBIA and TYK2). These associations were replicated in 9,079 European samples (six loci with a combined P < 5 × 10−8 and two loci with a combined P < 5 × 10−7). We also report compelling evidence for an interaction between the HLA-C and ERAP1 loci (combined P = 6.95 × 10−6). ERAP1 plays an important role in MHC class I peptide processing. ERAP1 variants only influenced psoriasis susceptibility in individuals carrying the HLA-C risk allele. Our findings implicate pathways that integrate epidermal barrier dysfunction with innate and adaptive immune dysregulation in psoriasis pathogenesis.


Genes, Chromosomes and Cancer | 2003

DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones

Heike Fiegler; Philippa Carr; Eleanor J. Douglas; Deborah C. Burford; Sarah Hunt; James Smith; David Vetrie; Patricia Gorman; Ian Tomlinson; Nigel P. Carter

We have designed DOP‐PCR primers specifically for the amplification of large insert clones for use in the construction of DNA microarrays. A bioinformatic approach was used to construct primers that were efficient in the general amplification of human DNA but were poor at amplifying E. coli DNA, a common contaminant of DNA preparations from large insert clones. We chose the three most selective primers for use in printing DNA microarrays. DNA combined from the amplification of large insert clones by use of these three primers and spotted onto glass slides showed more than a sixfold increase in the human to E. coli hybridization ratio when compared to the standard DOP‐PCR primer, 6MW. The microarrays reproducibly delineated previously characterized gains and deletions in a cancer cell line and identified a small gain not detected by use of conventional CGH. We also describe a method for the bulk testing of the hybridization characteristics of chromosome‐specific clones spotted on microarrays by use of DNA amplified from flow‐sorted chromosomes. Finally, we describe a set of clones selected from the publicly available Golden Path of the human genome at 1‐Mb intervals and a view in the Ensembl genome browser from which data required for the use of these clones in array CGH and other experiments can be downloaded across the Internet.


Nature Genetics | 2011

Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease.

Gosia Trynka; Karen A. Hunt; Nicholas A. Bockett; Jihane Romanos; Vanisha Mistry; Agata Szperl; Sjoerd F. Bakker; Maria Teresa Bardella; Leena Bhaw-Rosun; Gemma Castillejo; Emilio G. de la Concha; Rodrigo Coutinho de Almeida; Kerith Rae M Dias; Cleo C. van Diemen; P Dubois; Richard H. Duerr; Sarah Edkins; Lude Franke; Karin Fransen; Javier Gutierrez; Graham A. Heap; Barbara Hrdlickova; Sarah Hunt; Leticia Plaza Izurieta; Valentina Izzo; Leo A. B. Joosten; Cordelia Langford; Maria Cristina Mazzilli; Charles A. Mein; Vandana Midah

Using variants from the 1000 Genomes Project pilot European CEU dataset and data from additional resequencing studies, we densely genotyped 183 non-HLA risk loci previously associated with immune-mediated diseases in 12,041 individuals with celiac disease (cases) and 12,228 controls. We identified 13 new celiac disease risk loci reaching genome-wide significance, bringing the number of known loci (including the HLA locus) to 40. We found multiple independent association signals at over one-third of these loci, a finding that is attributable to a combination of common, low-frequency and rare genetic variants. Compared to previously available data such as those from HapMap3, our dense genotyping in a large sample collection provided a higher resolution of the pattern of linkage disequilibrium and suggested localization of many signals to finer scale regions. In particular, 29 of the 54 fine-mapped signals seemed to be localized to single genes and, in some instances, to gene regulatory elements. Altogether, we define the complex genetic architecture of the risk regions of and refine the risk signals for celiac disease, providing the next step toward uncovering the causal mechanisms of the disease.


Pharmacogenomics Journal | 2005

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

Mia Wadelius; Leslie Y. Chen; K. Downes; Jilur Ghori; Sarah Hunt; Niclas Eriksson; Ola Wallerman; Håkan Melhus; Claes Wadelius; David R. Bentley; Panos Deloukas

We report a novel combination of factors that explains almost 60% of variable response to warfarin. Warfarin is a widely used anticoagulant, which acts through interference with vitamin K epoxide reductase that is encoded by VKORC1. In the next step of the vitamin K cycle, gamma-glutamyl carboxylase encoded by GGCX uses reduced vitamin K to activate clotting factors. We genotyped 201 warfarin-treated patients for common polymorphisms in VKORC1 and GGCX. All the five VKORC1 single-nucleotide polymorphisms covary significantly with warfarin dose, and explain 29–30% of variance in dose. Thus, VKORC1 has a larger impact than cytochrome P450 2C9, which explains 12% of variance in dose. In addition, one GGCX SNP showed a small but significant effect on warfarin dose. Incorrect dosage, especially during the initial phase of treatment, carries a high risk of either severe bleeding or failure to prevent thromboembolism. Genotype-based dose predictions may in future enable personalised drug treatment from the start of warfarin therapy.


Scopus | 2011

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

David Evans; Alexander Dilthey; M. Pirinen; Tetyana Zayats; C. C. A. Spencer; Z. Su; Céline Bellenguez; Colin Freeman; Amy Strange; Gilean McVean; Peter Donnelly; J. J. Pointon; David Harvey; L. H. Appleton; T. Wordsworth; Tugce Karaderi; C Farrar; Paul Bowness; B. P. Wordsworth; Grazyna Kochan; U. Opperman; M Stone; L. Moutsianis; Stephen Leslie; Tony J. Kenna; Gethin P. Thomas; Linda A. Bradbury; Patrick Danoy; Matthew A. Brown; M. Ward

Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. Here we report the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 × 10−8 in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all our datasets (P < 5 × 10−6 overall, with support in each of the three datasets studied). We also show that polymorphisms of ERAP1, which encodes an endoplasmic reticulum aminopeptidase involved in peptide trimming before HLA class I presentation, only affect ankylosing spondylitis risk in HLA-B27–positive individuals. These findings provide strong evidence that HLA-B27 operates in ankylosing spondylitis through a mechanism involving aberrant processing of antigenic peptides.


Genome Biology | 2016

The Ensembl Variant Effect Predictor

William M. McLaren; Laurent Gil; Sarah Hunt; Harpreet Singh Riat; Graham R. S. Ritchie; Anja Thormann; Paul Flicek; Fiona Cunningham

The Ensembl Variant Effect Predictor is a powerful toolset for the analysis, annotation, and prioritization of genomic variants in coding and non-coding regions. It provides access to an extensive collection of genomic annotation, with a variety of interfaces to suit different requirements, and simple options for configuring and extending analysis. It is open source, free to use, and supports full reproducibility of results. The Ensembl Variant Effect Predictor can simplify and accelerate variant interpretation in a wide range of study designs.


Nature Genetics | 2008

Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

Sheila Fisher; Mark Tremelling; Carl A. Anderson; Rhian Gwilliam; Suzannah Bumpstead; Natalie J. Prescott; Elaine R. Nimmo; Dunecan Massey; Carlo Berzuini; Christopher M. Johnson; Jeffrey C. Barrett; Fraser Cummings; Hazel E. Drummond; Charlie W. Lees; Clive M. Onnie; Catherine Hanson; Katarzyna Blaszczyk; Michael Inouye; Philip Ewels; Radhi Ravindrarajah; Andrew Keniry; Sarah Hunt; Martyn J. Carter; Nicholas J. Watkins; Willem H. Ouwehand; Cathryn M. Lewis; L R Cardon; Alan J. Lobo; Alastair Forbes; Jeremy Sanderson

We report results of a nonsynonymous SNP scan for ulcerative colitis and identify a previously unknown susceptibility locus at ECM1. We also show that several risk loci are common to ulcerative colitis and Crohns disease (IL23R, IL12B, HLA, NKX2-3 and MST1), whereas autophagy genes ATG16L1 and IRGM, along with NOD2 (also known as CARD15), are specific for Crohns disease. These data provide the first detailed illustration of the genetic relationship between these common inflammatory bowel diseases.


Nature Genetics | 2009

Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

Jeffrey C. Barrett; James C. Lee; Charles W. Lees; Natalie J. Prescott; Carl A. Anderson; Anne Phillips; Emma Wesley; K. Parnell; Hu Zhang; Hazel E. Drummond; Elaine R. Nimmo; Dunecan Massey; Kasia Blaszczyk; Tim Elliott; L Cotterill; Helen Dallal; Alan J. Lobo; Craig Mowat; Jeremy Sanderson; Derek P. Jewell; William G. Newman; Cathryn Edwards; Tariq Ahmad; John C. Mansfield; Jack Satsangi; Miles Parkes; Christopher G. Mathew; Peter Donnelly; Leena Peltonen; Jenefer M. Blackwell

Ulcerative colitis is a common form of inflammatory bowel disease with a complex etiology. As part of the Wellcome Trust Case Control Consortium 2, we performed a genome-wide association scan for ulcerative colitis in 2,361 cases and 5,417 controls. Loci showing evidence of association at P < 1 × 10−5 were followed up by genotyping in an independent set of 2,321 cases and 4,818 controls. We find genome-wide significant evidence of association at three new loci, each containing at least one biologically relevant candidate gene, on chromosomes 20q13 (HNF4A; P = 3.2 × 10−17), 16q22 (CDH1 and CDH3; P = 2.8 × 10−8) and 7q31 (LAMB1; P = 3.0 × 10−8). Of note, CDH1 has recently been associated with susceptibility to colorectal cancer, an established complication of longstanding ulcerative colitis. The new associations suggest that changes in the integrity of the intestinal epithelial barrier may contribute to the pathogenesis of ulcerative colitis.


Advances in The Study of Behavior | 2000

Ultraviolet Vision in Birds

Innes C. Cuthill; Julian C. Partridge; Andrew T. D. Bennett; Stuart C. Church; Nathan S. Hart; Sarah Hunt

Publisher Summary Birds can see ultraviolet (UV) light because, unlike humans, their lenses and other ocular media transmit UV, and they possess a class of photoreceptor, which is maximally sensitive to violet or UV light, depending on the species. Birds have a tetrachromatic color space, as compared to the trichromacy of humans. Birds, along with some reptiles and fish, also possess double cones in large numbers and a cone class. This chapter discusses a range of behavioral experiments, from several species, which show that UV information is utilized in behavioral decisions, notably in foraging and signaling. Removal of UV wavelengths affects mate choice even in species that are colorful to humans. These studies emphasize that avian and human color perceptions are different and that the use of human color standards, and even artificial lighting, may produce misleading results. However, genuinely objective measures of color are available, as are, importantly, models for mapping the measured spectra into an avian color space.

Collaboration


Dive into the Sarah Hunt's collaboration.

Top Co-Authors

Avatar

Panos Deloukas

Queen Mary University of London

View shared research outputs
Top Co-Authors

Avatar

Suzannah Bumpstead

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sarah Edkins

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cordelia Langford

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Elvira Bramon

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jenefer M. Blackwell

University of Western Australia

View shared research outputs
Researchain Logo
Decentralizing Knowledge